Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies

Olagunju, A (2019) Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies. European Journal of Pharmaceutical Sciences.

Access the full-text of this item by clicking on the Open Access link.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	09 Oct 2020 12:47
Last Modified:	19 Jan 2023 00:22
DOI:	10.1016/j.ejps.2019.105068
Open Access URL:	https://doi.org/10.1016/j.ejps.2019.105068
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3058521

Available Versions of this Item

• Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies. (deposited 16 Oct 2019 13:59)
  • Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies. (deposited 09 Oct 2020 12:47) [Currently Displayed]